PACS Group, Inc.
PACS Healthcare Medical Care Facilities
PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.
- Revenue
- +11.5%
- EPS
- +16.4%
- Free cash flow
- −4.31%
- Total debt
- +7.48%
Quarter to September 2026, against a year earlier
Follow PACS
Alert me
PACS Group, Inc. (PACS) P/S ratio
As of 5 November 2026, PACS Group, Inc. (PACS) trades at a P/S ratio of 1.4×. Over the past ten years it has ranged from 0.3× (September 2025) to 1.8× (September 2024); the current reading is higher than 88% of that period. That is above the Medical Care Facilities industry median of 1.0× and below the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 1.1× | 141.14% |
| FY2024 | 0.5× | (47.24%) |
| FY2023 | 0.9× | 0.00% |
| FY2022 | 0.9× | 0.00% |
| FY2021 | 0.9× | — |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 1.2× | (5.03%) |
| Jun 2026 | 1.2× | 30.77% |
| Mar 2026 | 0.9× | (18.08%) |
| Dec 2025 | 1.1× | 171.00% |
| 11 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | 0.5× |
| UHS Universal Health Services, Inc. compare | 0.6× |
| OPCH Option Care Health, Inc. compare | 0.8× |
| DVA DaVita Inc. compare | 0.9× |
| PACS PACS Group, Inc. | 1.4× |
| ENSG The Ensign Group, Inc. compare | 1.9× |
| CON Concentra Group Holdings Parent, Inc. compare | 2.3× |
| CHE Chemed Corporation compare | 2.6× |
| LFST LifeStance Health Group, Inc. compare | 3.1× |
| Medical Care Facilities industry median | 1.0× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on PACS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Beneish M-score
- The full statement